MIGUEL ANGEL SERRA DESFILIS-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

2021

  1. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  2. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

    Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171

2011

  1. Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies

    International Journal of Molecular Medicine, Vol. 27, Núm. 1, pp. 111-117

2007

  1. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

    Journal of Molecular Medicine, Vol. 85, Núm. 3, pp. 233-241

1998

  1. Influence of pretreatment lesions on histologic response to interferon therapy in chronic hepatitis C

    Journal of Clinical Gastroenterology, Vol. 26, Núm. 4, pp. 296-299

1993

  1. Chronic hepatitis and cirrhosis: Evaluation by means of MR imaging with histologic correlation

    Radiology, Vol. 188, Núm. 1, pp. 37-43